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Different combinations and relative quantities of three connexins—connexin43, connexin40 and connexin45—are expressed in different
subsets of cardiomyocyte. In the healthy heart, gap junctions assembled from these different connexin combinations form the cell-to-cell
pathways for the precisely orchestrated patterns of current flow that govern the normal heart rhythm. Remodelling of gap junction organization
and connexin expression is a conspicuous feature of human heart disease in which there is an arrhythmic tendency. This remodelling may take
the form of structural remodelling, involving disturbances in the distribution of gap junctions (i.e., disruption of the normal ordered pathways for
cell-to-cell conduction), and remodelling of connexin expression, involving alteration in the amount or type of connexin(s) present. Most
notable among quantitative alterations in connexin expression is a reduction in ventricular connexin43 levels in human congestive heart failure.
By correlating data from studies in experimental animal models, gap junction and connexin remodelling emerges as a factor to be considered in
understanding the pro-arrhythmic substrate characteristic of many forms of heart disease. However, our knowledge of the functional correlates
of the specific patterns of multiple connexin expression found in different regions of the heart in health and disease remains rudimentary, and the
development of new experimental cell models heralds advances in this area over the next few years.
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Sequential contraction of the cardiac chambers depends
on orderly spread of the wave of electrical excitation from
one cardiomyocyte to the next, throughout the heart. The
pathways enabling this cell-to-cell current flow are formed
by the gap junctions that link individual myocytes into a
functional syncitium. Cardiac gap junctions vary in size,
abundance, distribution and connexin make-up according to
their location within the different myocardial tissues of the
heart. Moreover, alterations in the organization of gap
junctions and expression of connexins accompany the
pathogenesis of heart disease. The idea has thus grown that
specific features of gap junction organization and connexin
expression may be central to the electromechanical function
of the heart in health and disease. In this review, we focus on
the nature and possible significance of remodelling of gap0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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heart disease, set within the context of knowledge on the
normal heart, and drawing on selected correlative studies on
animal and cell models.2. Gap junctions and connexin expression in
cardiomyocytes of the normal heart
An understanding of gap junction organization and con-
nexin expression in the normal heart is a prerequisite to the
interpretation of altered expression patterns or remodelling
processes that may occur in cardiac disease. As widely
documented in the literature, connexin43 is the predominant
connexin expressed by cardiomyocytes, occurring in abun-
dance in adult working ventricular and atrial cardiomyo-
cytes of all mammalian species, including human [1–3].
Connexins 40 and 45 are also expressed in lower overall
quantities, though in specific localized sites the expression
of either of these connexins may exceed that of connexin43.
Numerous studies have demonstrated that these are not
random variations but that the three connexins are expressed
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chamber-related, myocyte-type-specific and developmental-
ly regulated manner [1–10].
The working (contractile) cardiomyocytes of the ventricle
are extensively interconnected by clusters of connexin43-
containing gap junctions located at the intercalated disks (Fig.
1). The intercalated disks of working ventricular myocardium
have a step-like configuration, with the gap junctions situated
predominantly in the ‘‘horizontal’’-facing segments of these
steps rather than the vertical segments [11–13], and partic-
ularly large gap junctions typically circumscribing the disk
periphery [14]. Features of gap junction organization such as
this, together with aspects of tissue architecture such as the
size and shape of the cells, combine to encourage preferential
propagation of the impulse in the longitudinal axis, thus
contributing to the normal pattern of anisotropic spread of
the impulse of healthy ventricular myocardium.
Atrial cardiomyocytes are slender cells compared with
their ventricular counterparts, with shorter, less elaborate
intercalated disks. The gap junctions of atrial myocytes of
most mammalian species, including humans, contain abun-
dant connexin40 [3,15], co-localized with connexin43 with-
in the same individual gap-junctional plaques [9]. Working
ventricular myocytes, by contrast, normally lack detectable
connexin40. In both ventricular and atrial human working
myocardium, connexin45 is present in very low quantities,
with slightly higher levels in the atria than the ventricles
[3,10,15].
The specialized cardiomyocytes of the impulse genera-
tion and conduction system are morphologically quite
distinct from the working ventricular and atrial cells [16].Fig. 1. Reconstruction of serial optical sections through an isolated
ventricular myocyte labelled for connexin43 (green) illustrating localization
of the gap junctions in clusters at the intercalated disks. The nuclei are
counterstained with propidium iodide (red). Bar marker =100 Am.The myocytes of the sinoatrial node, the site of impulse
generation, and those of the atrioventricular node (Fig. 2),
the site at which the impulse is slowed before being routed
to the ventricles, are equipped with small, sparse, dispersed
gap junctions containing connexin45 [17–19], a connexin
that forms low conductance channels in vitro [20–22].
These gap junction features of nodal myocytes suggest
relatively poor coupling, a property which in the atrioven-
tricular node is linked to slowing of conduction and hence
sequential contraction of the atria and ventricles. In the
sinoatrial node of the rabbit, the connexin45-positive sino-
atrial node is delineated from the surrounding atrial myo-
cardium by a connective tissue layer, except at a restricted
zone of connexin45/connexin43 co-expression at the nodal/
crista terminalis border. These features may contribute to the
ability of the sinoatrial node to drive the large mass of
surrounding atrial tissue while remaining protected from its
hyperpolarizing influence, with the zone of connexin45/
connexin43 co-expression possibly serving as the exit route
for the impulse into the atrial tissue [18]. Whether similar
features occur in the human sinoatrial node is unknown.
Although connexin45 is the predominant atrioventricular
nodal connexin, common to all mammalian species so far
examined, some species variation involving limited co-
expression of connexins 40 and 43 may occur. In particular,
there are indications that larger mammals, which may have
less need for atrioventricular nodal impulse delay, express
connexin43 and/or connexin40 in the atrioventricular node
in addition to connexin45 [23]. In the rodent, the spatial
pattern of expression of connexin45 reveals that the atrio-
ventricular node and His bundle form part of an elaborately
extended central conduction system circumscribing the
atrioventricular and outflow junctional regions [17], though
the extent of this feature in other species is yet to be
determined.
In addition to connexin45, cardiomyocytes of the His-
Purkinje conduction system in most mammals, including
man, express connexin40, a connexin associated with high
conductance channels [6,8–10,24–26]. Prominent immu-
nolabelling for this connexin, in the form of large, abundant
gap junctions, correlates with the fast conduction properties
of the bundle branches and Purkinje fiber system which
facilitate rapid distribution of the impulse throughout the
working ventricular myocardium. In rodents, connexin45 is
co-expressed with connexin40 in a central zone of the
bundle branches and Purkinje fibers, enveloped by an outer
zone in which only connexin45 is found [17]. Again,
whether this feature is present in humans is at present
unknown.
New opportunities for investigating the role of the three
connexins in cardiac function came with the development of
transgenic animals in which expression of specific connex-
ins may be ablated, or one connexin type is substituted for
another. From the perspective of analysing the electrophys-
iological aspects of connexin function in the adult heart,
however, this approach can have limitations arising from a
Fig. 2. Confocal micrographs showing the distribution of connexins 45 and 40 in the atrioventricular node of a heart from a 3-month-old mouse, cut in the plane
shown in the adjacent diagrammatic representation of the conduction tissues (A). Connexin45 (B) is distributed throughout the whole nodal area, visible as
bright, green spots of label, whereas connexin40 labelling (C) is confined to the distal part of the node. Colocalization of the two connexins (D) highlights their
relative spatial patterns of expression. Bar marker =125 Am.
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The first connexin knock-out studies in mice demonstrated
that absence of connexin43 was compatible with survival to
term but the animals died shortly after birth owing to
obstruction of the right outflow tract [27], a developmental
abnormality resulting from defective migration of neural
crest cells [28,29]. To determine the effects of lack of
connexin43 on the cardiomyocyte after birth, Gutstein et
al. [30] generated mice with cardiac-specific knock-out of
Cx43, thereby circumventing the non-cardiac myocyte re-
lated developmental defect [29]. The resultant mice showed
marked reduction of ventricular conduction velocity and
developed lethal spontaneous ventricular arrhythmia by 2
months of age, indicating that cardiomyocyte connexin43 is
essential for function of the more mature ventricle but not
for the early neonatal ventricle where the low amounts ofconnexin45 still present are apparently sufficient to maintain
impulse propagation. Whether the progressive spatial
remodelling of gap junctions into intercalated disk clusters
that takes place during the postnatal period [31,32] also
contributes to increased susceptibility to arrhythmia in these
mice is unknown.
Knock-out of connexin45 in mice results in death at
about embryonic day 10, demonstrating that expression of
this connexin is vital for development [33,34]; a cardiac-
restricted knock-out of this connexin will thus be required to
help determine cardiac specific functions. Connexin40
knock-out is, however, compatible with survival, but leads
to impairment of conduction through the conduction system
[35–39]. Residual ability of the His-Purkinje system to
support conduction in the absence of connexin40 is attrib-
utable to the presence of connexin45 which, unlike con-
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[17]. Replacement of connexin43 by connexin40 or con-
nexin32 rescues the postnatal lethality of connexin43
knock-out and overall ECG parameters of the heart are
unaltered, though the mice are prone to spontaneous ven-
tricular arrhythmia [40]. Thus, one connexin type may
substitute functionally for another to quite a remarkable
degree, though some abnormalities arise, indicating that
specific connexins have the capacity to confer subtly dis-
tinctive properties [40]. Interpretation of results from the
knock-out/knock-in approach is confounded by the difficul-
ty in establishing whether the replacement connexin is
expressed at the same level as the original connexin in the
wild-type animal; hence, the resultant functional properties
may be due to a combination of altered expression of
connexin type and amount.
Relating findings on transgenic mice to the human
depends on a sound understanding of the similarities and
differences of the connexin expression of these two species
[41,42]. At present, significant gaps remain in our knowl-
edge of connexin expression patterns in the human impulse
generation and conduction system, and during human
development.Fig. 3. Remodelling of connexin43 gap junctions in myocardium bordering
infarct scar tissue from human ventricle. The immunonegative area at the
bottom of this immunoconfocal image is part of an infarct scar (i).
Myocardium approaches the scar tissue from the upper right. The upper to
mid right area of the myocardium shows short lines of immunolabelling at
intervals, representing linear rows of gap junctions organized in intercalated
disks between myocytes. However, this normal ordered arrangement is
severely disrupted in myocardium close to the infarct scar (mid-right
through to lower part of the image) where many of the immunolabelled gap-
junctional spots appear strewn along the lateral borders of the myocytes.
From [44]. Bar marker =100 Am.3. Altered gap junction and connexin expression in
human heart disease
Notwithstanding the remaining gaps in knowledge, the
role of gap junctions as the cell-to-cell pathways for the
orderly spread of current flow underlying synchronous
contraction in the healthy heart led to the question being
posed as to whether alterations of gap junction organization
and connexin expression might contribute to abnormal
conduction and arrhythmogenesis in the diseased human
heart [43,44]. Arrhythmogenesis is, of course, multifactorial
in origin, involving an interplay between gap-junctional
coupling, membrane excitability and cell and tissue archi-
tecture [45–47]. Moreover, gap-junctional coupling is itself
determined by multiple factors including, for example,
channel gating and the assembly/disassembly of functional
gap junction plaques, as well as potentially by the pattern,
amount and types of connexin expressed. Thus, it is
important to bear in mind that findings on gap junction
organization and connexin expression in diseased human
tissue represent one facet of one potential contributor to the
arrhythmogenic substrate. In examining this topic, it is
convenient to consider gap junction and connexin remodel-
ling under two, non-mutually exclusive categories, (i) struc-
tural remodelling, which refers to alteration in the distribu-
tion or organization of gap junctions, and (ii) remodelling of
connexin expression, involving changes in the amount and/
or types of connexin expressed.
The most striking form of structural remodelling
involves loss of the normal ordered distribution of con-
nexin43 gap junctions in the myocardial zone borderinginfarct scar tissue (Fig. 3), first reported in the ventricles of
patients with end-stage ischaemic heart disease [43]. The
infarct scar tissue is visualized as a patch that is immuno-
negative for connexin43, and connexin43 immunolabelling
in the border zone myocytes is typically scattered in
disordered fashion over the lateral surfaces of the cells
rather than in the polar, intercalated disk arrays character-
istic of normal myocardium. Electron microscopy reveals
that both true laterally disposed gap junctions that contact
adjacent cells, and annular profiles of apparently internal-
ized, non-functional gap-junctional membrane, contribute
to the dispersed connexin43 labelling patterns [43]. Gap
junction disarray of this type occurs not only in association
with established infarct scar tissue, but has been shown in
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dial infarction [48]. A strikingly similar lateralization of
gap junctions accompanies experimentally induced hyper-
trophy of the right and left ventricle of the rat [49,50], and,
in the former, correlates with a reduction in longitudinal
conduction velocity [49]. Although no corresponding
changes are obvious in hypertrophy associated with coro-
nary heart disease in humans undergoing coronary by-pass
operations, disordered arrangements of ventricular con-
nexin43 gap junctions are prominent in human hypertro-
phic cardiomyopathy, the most common cause of sudden
cardiac death due to arrhythmia in young adults [51].
Furthermore, in a canine model of infarction, border zone
gap junction disarray extending across the epicardial layer
correlates spatially with the central common pathway of
figure-of-eight reentrant circuits [52].
A more subtle form of structural remodelling is associ-
ated with hibernating myocardium, a state of impaired
myocardial contraction in patients with coronary artery
disease [53]. The large connexin43 gap junctions typically
found at the periphery of the intercalated disk are markedly
smaller in size in hibernating myocardium compared with
those of reversibly ischaemic regions and those of normally
perfused regions of the same heart [53]. Thus, a possible
link was proposed between disease-related gap junction
remodelling and defective cardiac contraction. The structur-
al remodelling of gap junctions in hibernating myocardiumn
occurs hand-in-hand with remodelling (i.e., alteration) of
connexin expression, as the overall amount of connexin43Fig. 4. (A) Typical Western blot analysis of connexin43 in heart failure
patients. The upper panel shows analysis of left ventricular tissue (LV); the
lower panel shows the analysis of right ventricular tissue (RV) of the same
patients. The classification of the diseased samples is indicated at the top of
each panel (ICM: ischaemic cardiomyopathy; DCM: idiopathic dilated
cardiomyopathy). The control samples are on the left (LVC, left ventricle
control; RVC, right ventricle control). Cx43=connexin43 detected on
immunoreplica; Act=actin stained by Coomassie blue. The Coomassie blue
staining indicates that similar amounts of proteins were run. Note that the
control and right ventricular samples appear to contain more actin (and
myosin, not shown) than the diseased left ventricular samples, for the same
amount of protein loaded (4 Ag total protein for immunoreplication and
10 Ag for Coomassie blue staining) owing to fibrosis in the diseased tissue.
The immunoreaction was therefore normalized to relate the connexin
quantities to the myocytic component. The lower amounts of contractile
protein in the diseased left ventricular samples indicate the presence of
substantial fibrosis that was not obvious in the right ventricular samples.
Identical samples (LVC1 and RVC1) are present in both analyses to permit
gel-to-gel comparison. (B) Bar chart showing quantification of connexin43
in patients with heart failure. Data are expressed as a percentage of the left
ventricle control after normalization using the actin-stained band. There is
no significant difference in connexin43 levels between the ischaemic
cardiomyopathy and idiopathic dilated cardiomyopathy groups; hence,
these were amalgamated to give nine diseased samples (Dis). The control
data (Cont) are from four undiseased hearts. On average, there is a f50%
reduction in Cx43 signal in the diseased compared to the control ventricles
(unpaired t test). However, expression levels are heterogeneous and,
although averaging to similar percentage reduction per heart, some lysates
revealed much lower levels of Cx43 levels in some regions within the
ventricle. For further details, see Ref. [54].immunolabelling per intercalated disk is reduced in the
hibernating and reversibly ischaemic samples.
Down-regulation of connexin43 is the most extensively
documented quantitative alteration in connexin expression
in human heart disease (Fig. 4). Northern and Western blot
analyses demonstrate a substantial reduction in connexin43
transcript and protein levels in the left ventricles of trans-
plant patients with end-stage congestive heart failure [54].
This remodelling of connexin expression is prominent
irrespective of whether heart failure is due to idiopathic
dilated cardiomyopathy or ischaemic heart disease. Data
from quantitative immunoconfocal microscopy of tissue
from by-pass patients [55] suggest that in ischaemic heart
disease, reduction in ventricular connexin43 develops long
before terminal heart failure.
The possible functional significance of reduced con-
nexin43 levels in the diseased human ventricle has been
open to divergent opinions. At the outset, it is important to
emphasize that total connexin levels may be regarded as
indicators of the potential capacity for cell-to-cell commu-
nication, but do not provide information on the quantity of
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ling studies predict that reductions of up to 40% in gap
junction content (without change in junction size) would be
unlikely to have a major effect on conduction velocity [56].
Hence, a reduction of connexin43 in the diseased ventricle
may not, per se, be of functional relevance. On the other
hand, in view of the complex relationship between passive
and active membrane properties [45,57,58], and the assump-
tions inherent in computer modelling, prediction of the
effects of reduced connexin43 levels in vivo is not neces-
sarily a straightforward matter. Results of studies in the
intact heart are therefore instructive in order to determine the
net effects of multiple potentially interacting factors in vivo.
In transgenic mice generated to give cardiac specific loss
of connexin43, the magnitude of connexin43 reduction
associated with sudden death due to spontaneous ventricular
arrhythmia is in the order of 86–95% [30], much lower than
the average reduction found in the diseased human ventricle
(f50%). On the other hand, in intact isolated hearts of
transgenic mice expressing half the normal level of con-
nexin43, experimental ischemia reportedly leads to a
marked increase in incidence, frequency and duration of
ventricular tachycardias [59] even though there may only be
a modest reduction in conduction velocities [60,61]. In the
failing human ventricle, considerable variation is apparent in
the extent of connexin43 reduction between and, in partic-
ular, within hearts, some regions of some diseased hearts
reaching a reduction of >90% of control values [54]. Thus,
average values for the overall reduction in ventricular
connexin43 disguise considerable spatial heterogeneity in
the extent of the reduction. The existence of this heteroge-
neity could lead to exaggeration of inhomogeneities in
resting potential and action potential upstroke velocity and
duration, affecting individual cell excitability and refractory
period, dispersion of which is a key pro-arrhythmic factor.Fig. 5. (A) Northern blot analysis comparing ventricular expression of Cx40
transcript between idiopathic dilated cardiomyopathy (DCM), ischaemic
cardiomyopathy (ICM) and normal controls. Visual inspection reveals
prominent signal for Cx40 mRNA in most samples from the ischaemic
hearts compared with controls and DCM samples. The quantification below
shows a significant up-regulation of Cx40 expression in the ischaemic
ventricles, more so in the left ventricle than the right. Samples were
normalized using a hybridization with the 18S rRNA (not shown) in order
to compensate for gel loading and to relate Cx40 signals to a constant
cellular parameter (LV, left ventricle; RV, right ventricle). (B) Immuno-
confocal quantification of Cx40 immunoreactivity expressed as area of
Cx40 signal per intercalated disk area in myocytes at the endocardial
surface of the ventricle in control, DCM and ICM groups (analysis by
unpaired Student t test) in relation to cell layer, as measured by number of
cells from the endocardial surface. Data were obtained from en face-viewed
intercalated disks in left ventricular tissue. Note that positive Cx40 labelling
was never observed deeper than 20–25 cells from endocardial surface in
control or idiopathic dilated ventricle. In ischaemic cardiomyopathy,
individual cells contain more Cx40 signal than do those of controls or
those of dilated hearts, and expression continues to a much greater depth
from the endocardial surface. For further details, see Ref. [54].Inhomogeneous wavefront propagation could in turn lead to
asynchronous myocyte contraction.
A neat experimental demonstration that remodelling of
cardiac connexin43 expression is indeed linked to dis-
Fig. 6. (A) Northern blot analysis comparing expression of Cx40, Cx43 and
Cx45 transcripts between patients who subsequently developed post-
operative atrial fibrillation (AT. FIB.) with those who did not (CONT.) The
18S hybridization was used to normalize the connexin mRNA expression.
(B) Quantification of Cx40, Cx43, and Cx45. The data presented per patient
show that Cx40 is expressed at significantly higher levels in the group that
subsequently developed post-operative atrial fibrillation. Cx43 and Cx45
are expressed at similar levels in both groups (analysis by unpaired t test).
For further details, see Ref. [15].
Fig. 7. Immunoconfocal staining of Cx40 in atrial myocardium of a normal
human heart illustrating the variation in Cx40 signal from abundant (left of
field) to low (delimited by arrow heads) over very short distance within the
tissue. This heterogeneity of Cx40 expression is observed in all human
atrial samples, regardless of pathology.
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work by Gutstein et al. [62] using chimeric mice created
from connexin43 deficient stem cells and blastocysts.
This approach was designed to give heterogeneous ex-
pression of connexin43 (i.e., a pattern resembling that
seen in heart failure), and the resultant experimental mice
were demonstrated to have both abnormal conduction
and contractile dysfunction, as originally hypothesized in
the human studies [43,53,54]. Thus, the spatially hetero-
geneous connexin43 down-regulation of the magnitude
and nature observed in the diseased human ventricle
could similarly predispose to arrhythmia and contractile
dysfunction.
Apart from reduced connexin43, the overall level of
connexin40 transcript is increased in the ventricles of
patients with congestive heart failure due to ischaemic
heart disease (Fig. 5) but not that due to idiopathic dilated
cardiomyopathy [54]. This increased connexin40 expres-
sion correlates with an increased depth of connexin40
expressing myocytes from the endocardial surface (i.e.,
in a position associated with and adjacent to that normallyassociated with Purkinje fibers) reminiscent of that
reported in ventricular hypertrophy in the rat [25]. The
significance of this expanded zone of connexin40 expres-
sion is unclear: one speculation is that it could represent a
type of compensatory response that might conceivably
improve depolarization from the conduction tissues in the
face of declining connexin43 levels; another is that it could
lead to heterogeneity of impulse propagation between
adjacent regions of myocardium and increase susceptibility
to arrhythmias.
Connexin40, apart from showing atypical site-specific
expression in the ischaemic ventricle, may also contribute to
arrhythmia in the atrium, specifically in post-operative atrial
fibrillation (Fig. 6). Atrial fibrillation has many interacting
causes, but levels of connexin40 at the upper range of
normal values, as determined in samples of atrial appendage
taken during coronary artery by-pass operation, are associ-
ated with an increased tendency of the patient subsequently
to develop atrial fibrillation [15]. At first sight, this corre-
lation might appear paradoxical. However, connexin40
immunolabelling in the human atrium, in contrast to atrial
connexin43, typically shows a markedly heterogeneous
distribution in the undiseased heart (Fig. 7). As discussed
above, the balance between connexin quantity and hetero-
geneity of its distribution may be key factors in suscepti-
bility to arrhythmia. In the case of the atrium, differences in
resistive properties and conduction velocities due to the
natural heterogeneity of atrial connexin40 may become
enhanced, and hence pro-arrhythmic, the higher the overall
levels of connexin40. It is important to emphasize that these
Fig. 8. Development of the transfected cell model. The same cell line (RLE)
was transfected with the same connexin but using two different plasmid
constructions. The top image (A) shows cells expressing two different
mRNAs (see diagram at the foot of the panel), one for the Cx45tag and one
for the geneticin resistance (G418R). The image below (B) shows cells
generating a single mRNA coding for both the Cx45tag and the
Hygromycin resistance (HygroR) with an IRES (see diagram at foot of
the panel). Immunostaining for Cx45tag was done using the V5 antibody.
There is marked heterogeneity of expression in cells expressing the two
separate mRNAs because expression of Cx45tag is not necessary for cell
survival. By comparison, note impressive homogeneity of expression in
cells expressing the bi-cistronic mRNA (B).
Fig. 9. Western blot analysis of connexin expression in cells transfected for
inducible expression. Inductions were for 48 h (Ind., noted + or  on top of
the picture). The left membrane (anti-Cx43) shows a HeLa Cx43-
transfectant using the Ecdysone system (HeLa IND43). Cx43 is clearly
up-regulated upon induction, although the IND promoter of the Ecdysone
system is still active even without induction. The two other membranes
illustrate HeLa cells transfected to express Cx43 using a CMV promoter
and an IRES sequence, and Cx40 using the Tet-Off system (HeLaCMV43/
TRE40). The middle panel shows that expression of Cx43 (anti-Cx43)
driven by a CMV promoter is not affected by the induction whilst Cx40
(panel anti-Cx40) is clearly up-regulated upon induction. Both systems
make suitable models for functional analysis; the level of expression is very
high upon induction to very low or undetectable without induction. Note
that the band just below the Cx40 band is also observed in wild-type HeLa
cells and is unrelated to Cx40.
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in later development of post-operative atrial fibrillation, an
entirely different situation from that of the alterations in gap
junctions and connexins that are suggested to be induced by
and hence perpetuate chronic atrial fibrillation [63–66].4. Future directions
From the findings discussed above, it is now clear that
remodelling of ventricular gap junctions—notably alteration
in the pattern of junctional distribution and reduced levels of
connexin43—does occur in defined categories of human
heart disease, and in at least some instances similar alter-
ations correlate with electrophysiologically identified pro-
arrhythmic changes in animal models. While electrophysi-
ological studies on transfected cells have emphasized the
distinctiveness of the channel properties conferred by dif-
ferent connexin types, work on genetically engineered mice
indicates that, at the level of the whole organ, a greater
capacity arguably exists for one connexin type to substitute
for the function of another than might originally have been
anticipated. Despite the exciting progress of the last decade,
there remain significant limitations in our attempts to define
the functional significance of the distinctive connexin ex-
pression patterns observed in specific regions of the healthy
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this field, an in vitro model, designed to express the same
combinations of connexins in the same relative quantities as
those found in vivo, and which is amenable to functional
analysis, could prove invaluable. To this end, we have
worked on developing such a model in which the expression
levels of different (multiple) connexins in transfected cells
are controlled using inducible promoters.
Previous work involving transfection of HeLa cells with
a single connexin has enabled determination of the proper-
ties of homomeric/homotypic [24,67,68] and homomeric/
heterotypic channels [69–71], and in ascribing functions to
different segments of the connexin molecule [72,73]. How-
ever, because these transfections use plasmids containing
two transcription units, one for the antibiotic resistance and
one for the gene of interest, this type of plasmid generates
two mRNAs with no selection pressure on the gene of
interest, that encoding the connexin. As a result, after a few
passages of the transfectants, the expression of the connexin
becomes heterogeneous. This does not constitute a problem
for functional analysis of single transfectants as only a few
channels are necessary to obtain measurements. However,
for studies on co-expression, the heterogeneity of expression
may result in major variations in the ratio of the two
connexins, leading to a broad variation in the associated
functional properties.
To overcome this problem of heterogeneity of expression
(Fig. 8A), we physically linked the connexin and antibiotic
resistance genes using an internal ribosome entry site
(IRES) sequence, thereby generating bi-cistronic mRNA.
Using this approach, homogeneous expression is consistent-
ly obtained throughout the culture (Fig. 8B). To make the
expression of the connexins inducible, we have engineered
two commercially available systems, the Tet-Off system
(Clontech) and the Ecdysone system (Invitrogen), to express
bi-cistronic mRNA coding for the resistance and the con-
nexin. This strategy combines imposition of selection pres-
sure on the (transfected) transcription factor (responsive to
tetracycline and/or ecdysone) with ability to assess the level
of induction using the antibiotic resistance. Using both these
inducible systems, we now have HeLa cell lines in which
the expression of connexins is adjustable (Fig. 9). In order to
obtain an accurate ratio of connexin expression in the co-
expressing cell lines or in the tissue that the cell lines are
designed to mimic, we introduced a V5 tag at the C-terminal
of the connexins. Assuming that the anti-V5 antibody reacts
identically with all our tagged connexins and that the V5
antigen does not alter the binding of our specific anti-
connexin antibodies to the tagged version, the V5 immuno-
reactivity can be used to calibrate the specific reaction with
anti-connexin antibodies in Western blots.
The transfected cell models provide a novel tool to
address key questions such as the influence of varying the
ratio of co-expressed connexins on intracellular resistance, a
major determinant of conduction velocity in myocardium. A
major hope is that these models will help us to ascribefunctional properties to the distinctive sets of connexin co-
expression patterns that are observed in the normal and
diseased heart, an aim that remains elusive despite the
wealth of new data generated from transgenic approaches.Acknowledgements
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